Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Jumonji domain containing 1C (
JMJD1C
) gene encodes the
Jumonji domain-containing protein 1C
(
JMJD1C
) and is a member of the jmJC domain-containing protein family involved in histone demethylation that is expressed in the brain. We report seven, unrelated patients with developmental delays or intellectual disability and heterozygous, de novo sequence variants in
JMJD1C
. All patients had developmental delays, but there were no consistent additional findings. Two patients were reported to have
seizures
for which there was no other identified cause. De novo, deleterious sequence variants in
JMJD1C
have previously been reported in patients with autism spectrum disorder and a phenotype resembling classical Rett syndrome, but only one
JMJD1C
variant has undergone functional evaluation. In all of the seven patients in this report, there was a plausible, alternative explanation for the neurocognitive phenotype or a modifying factor, such as an additional potentially pathogenic variant, presence of the variant in a population database, heteroplasmy for a mitochondrial variant or mosaicism for the
JMJD1C
variant. Although the de novo variants in
JMJD1C
are likely to be relevant to the developmental phenotypes observed in these patients, we conclude that further data supporting the association of
JMJD1C
variants with intellectual disability is still needed.
...
PMID:Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures. 3195 78